Link Hepatitis C Notifications to Treatment in Tasmania
- Conditions
- Hepatitis C
- Interventions
- Behavioral: Enhanced case management
- Registration Number
- NCT04510246
- Lead Sponsor
- Macfarlane Burnet Institute for Medical Research and Public Health Ltd
- Brief Summary
This project will utilise the notification process as a point of intervention to work with primary practitioners (GP) by contacting them directly when a notification of hepatitis C exposure is received by the Tasmanian department of Health (DoH). A designated role will exist within DoH of a specialist HCV health worker to contact GPs to provide supported assistance in the process of the follow up hepatitis C diagnoses with patients. The study will evaluate whether active follow up of providers with enhanced case management is effective in having patients linked to hepatitis C treatment compared to current standard of care of surveillance for new notifications. The study will also compare the cost-effectiveness of this approach compared to current standard of care after one of their patients is notified with a positive hepatitis C antibody result.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 170
- General Practitioners (GP) who have requested a hepatitis C test that leads to new or repeat notification to the Tasmanian Department of Health
- Not based in Tasmania
- Practitioner from correctional service
- Specialist
- Nurse practitioner who initiated test
- Sexual health service doctor
- Family planning
- Trainee
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Enhanced case management Practitioners randomised to the intervention arm will receive the standard of care surveillance letter if the notification is new. Both new and repeat notifications will receive further enhanced case support during the project if required. Support can be provided at the first phone call, or if accepted and required, in a 12-week period during which the DoH health care worker can do follow-up calls with the GP or directly with the patient to inform the patient and enhance linkage back to their GP. At the end of the 12-week period, a follow-up call we be carried out for the project evaluation.
- Primary Outcome Measures
Name Time Method Proportion of cases notified with hepatitis C who commence hepatitis C treatment The study follow up period is 12 weeks The primary outcome will be the proportion of cases notified with hepatitis C who commence hepatitis C treatment within 12 weeks of initial contact. This will be assessed using the information provided by practitioners at the 12-week follow-up phone call and will be compared across the two arms.
- Secondary Outcome Measures
Name Time Method Proportion of people diagnosed with hepatitis C with a documented HCV RNA test result The study follow up period is 12 weeks The the proportion of cases notified with hepatitis C with documented HCV RNA results within 12 weeks of initial contact. This will be assessed using lab data and information provided by practitioners.
Proportion of people diagnosed with hepatitis C completing treatment work-up blood tests The study follow up period is 12 weeks The the proportion of HCV RNA positive cases who completed treatment work up blood tests within 12 weeks of initial contact. This will be assessed using lab data and information provided by practitioners.
Proportion of people diagnosed with hepatitis C completing an appropriate course of hepatitis C treatment as prescribed The study follow up period is 12 weeks The the proportion of HCV cases who complete an appropriate course of prescribed hepatitis C treatment..
Trial Locations
- Locations (1)
Tasmanian Department of Health
🇦🇺Hobart, Tasmania, Australia